A genetic investigation of individuals in the Framingham Heart Study may prove useful to identify novel targets for the prevention or treatment of high blood pressure. The study, which takes a close look at networks of blood pressure-related genes, is published in the journal Molecular Systems Biology.
More than one billion people worldwide suffer from high blood pressure and this contributes significantly to deaths from cardiovascular disease. It is hoped that advances in understanding the genetic basis of how blood pressure is regulated will improve the prediction of susceptibility to cardiovascular disease and also provide insight into how individually tailored treatments for high blood pressure can reduce the risk of disease.
“For more than 50 years the Framingham Heart Study has been an invaluable source of research findings on the contributions of high blood pressure, high cholesterol, smoking and other factors to the development of cardiovascular disease,” says Daniel Levy, director of the Framingham Heart Study. “More recently we have launched a major initiative to identify and study the genes underlying cardiovascular and other chronic diseases in individuals taking part in the Framingham Heart Study since we believe that this research could lead to new treatments and better strategies for disease prevention.”
Dissecting genetic data to identify molecular alterations that lead to or cause disease is very challenging. In the present work, the authors developed a strategy that combines multiple types of large-scale genetic and molecular data. Specifically, the scientists first looked at a vast collection of gene expression data from 3679 individuals who were not receiving any drug treatment for high blood pressure. As a starting point, they combined information on likely genetic differences contributing to elevated blood pressure by incorporating genome-wide association studies with the gene expression data for all of the individuals they studied. As a next step, the researchers worked from the hypothesis that it would be the surrounding network of certain disease-causing genes that would have the most impact on blood pressure and disease susceptibility. Scientists have known for some time that looking at each gene in isolation is not a powerful enough way to determine how different genes underlie blood pressure and other complex traits. By looking at multiple genes and how they interact, the researchers were able to find four groups of genes linked to blood pressure that warranted further study to reveal key driver genes controlling blood pressure regulation.
“Our work was able to pinpoint several gene networks closely linked to the regulation of blood pressure,” says Tianxiao Huan, one of the lead authors of the study. “As a proof-of-concept, we validated one of these key driver genes, SH2B3, and demonstrated its relationship to hypertension in mice.”
The researchers revealed that mice lacking the Sh2b3 gene had normal blood pressure but showed an exaggerated blood pressure response to treatment with angiotensin-II, a naturally occurring hormone that causes blood vessels to contract. Adding further confidence that Sh2b3 can play a causal role in the dysregulation of blood pressure in humans, the scientists found that the genes predicted to be affected by Sh2b3 greatly overlapped with the set of genes whose expression is indeed affected in the mice that lack the Sh2b3 gene.
“Moving forward, it should be possible to study additional key driver genes in this way, which should help in our efforts to identify novel targets for the prevention and treatment of hypertension,” says Huan.
Integrative network analysis reveals molecular mechanisms of blood pressure regulation
Tianxiao Huan, Qingying Meng, Mohamed A. Saleh, Allison E. Norlander, Roby Joehanes, Jun Zhu, Brian H. Chen, Bin Zhang, Andrew D. Johnson, Saixia Ying, Paul Courchesne, Nalini Raghavachari, Richard Wang, Poching Liu, The International Consortium for Blood Pressure GWAS (ICBP), Christopher J. O'Donnell, Ramachandran Vasan, Peter J. Munson, Meena S.
Madhur, David G. Harrison, Xia Yang, and Daniel Levy
Read the paper:
Further information on Molecular Systems Biology is available at http://msb.embopress.org
Head | Public Relations and Communications
Editor, Molecular Systems Biology
Tel: +49 6221 8891 410
EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
For more information: www.embo.org
Yvonne Kaul | EMBO
Ambush in a petri dish
24.11.2017 | Friedrich-Schiller-Universität Jena
Meadows beat out shrubs when it comes to storing carbon
23.11.2017 | Norwegian University of Science and Technology
High-precision measurement of the g-factor eleven times more precise than before / Results indicate a strong similarity between protons and antiprotons
The magnetic moment of an individual proton is inconceivably small, but can still be quantified. The basis for undertaking this measurement was laid over ten...
Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
24.11.2017 | Physics and Astronomy
24.11.2017 | Health and Medicine
24.11.2017 | Earth Sciences